News | September 21, 2023
Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
This approval has come from the company's finished dosage form manufacturing facility
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Subscribe To Our Newsletter & Stay Updated
